Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets.
Todisco S, Musio B, Pesce V, Cavalluzzi MM, Petrosillo G, La Piana G, Sgobba MN, Schlosserová N, Cafferati Beltrame L, Di Lorenzo R, Tragni V, Marzulli D, Guerra L, De Grassi A, Gallo V, Volpicella M, Palese LL, Lentini G, Pierri CL.
Todisco S, et al. Among authors: pesce v.
Biochem Pharmacol. 2023 Feb;208:115405. doi: 10.1016/j.bcp.2022.115405. Epub 2023 Jan 2.
Biochem Pharmacol. 2023.
PMID: 36603686
Review.